A Phase 1 Study of the VEGF Receptor Tyrosine Kinase

Project: Research project

Project Details

Description

A Phase 1 Study of the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib (INLYTA) in Children with Relapsed Refractory Solid Tumors
StatusFinished
Effective start/end date7/30/142/28/17

Funding

  • Children's Hospital of Philadelphia

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.